Crossmark

A Comparative Investment Analysis of Batch Versus Continuous Pharmaceutical Manufacturing Technologies

Crossref DOI link: https://doi.org/10.1007/s12247-021-09612-y

Published Online: 2022-01-31

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rossi, Clifford V. https://orcid.org/0000-0002-7652-7330
Funding

Funding for this research was provided by:

U.S. Food and Drug Administration (U01FD005946)
License Information

Text and Data Mining valid from 2022-01-31

Version of Record valid from 2022-01-31
More Information

Article History

Accepted: 1 December 2021

First Online: 31 January 2022